According to a new study, a recently uncovered axis connecting muscles and the pituitary gland could play an unexpected role in female fertility. Indeed, a research team from McGill University ...

Studies suggest that by acting as a decoy receptor for myostatin—a protein believed to inhibit muscular tissue development—ACE-031 may offer novel avenues for research into wasting disorders that ...

there is more muscle growth and weight loss. Based on the trial results, Scholar Rock, is now seeking FDA approval for their myostatin inhibitor, which is based on a fundamental mechanism ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Bio (IBIO) announced data from a non-GLP non-human primate pharmacokinetics study suggesting IBIO-600, the company’s novel lead asset and a ...

DMD treatment KER-065 showed a good safety profile in a Phase 1 clinical trial with no serious side effects seen in healthy ...

Unlike most myokines that increase with exercise, myostatin levels decrease in response to resistance training. As a negative regulator of muscle growth, this reduction removes the brakes on ...

GLP, nonhuman primate (NHP) pharmacokinetic (PK) study of IBIO-600, the company’s lead asset and a potentially best-in-class long-acting anti-myostatin antibody designed for subcutaneous ...

A Prescription Drug User Fee Act (PDUFA) target action date for apitegromab has been set for Sept. 22, 2025.